Igenomix Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 560

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 2

Igenomix General Information

Description

Provider of genetic testing services intended for reproductive health clinics. The company specializes in offering a range of services in reproductive genetics and specializes including NACE (non-invasive prenatal test), CGT (carrier genetic test), PGD (preimplantation genetic diagnosis), ERA (endometrial receptivity array) and creates and develops tools for the reproductive medicine field, thereby helping the clients couples who are trying to conceive.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 7955 Northwest 12th Street
  • Suite 415
  • Miami, FL 33126
  • United States
+1 (305) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Igenomix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Igenomix‘s full profile, request access.

Request a free trial

Igenomix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of genetic testing services intended for reproductive health clinics. The company specializes in offering a ran
Laboratory Services (Healthcare)
Miami, FL
560 As of 2021
0.000 0000-00-00
000000&0

000 00

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000000000 00000000
Shenzhen, China
0000 As of 0000
00000
000000000 00000

000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
0000000000 00000000
Vista, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Igenomix Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BGI Genomics Formerly VC-backed Shenzhen, China 0000 00000 000000000 00000
Exagen Formerly VC-backed Vista, CA 000 00000 000000000 00000
Admera Health Venture Capital-Backed South Plainfield, NJ 00 00000 00000
MedGenome Private Equity-Backed Foster City, CA 0000 00000 00000000000 00000
ARUP Laboratories Corporation Salt Lake City, UT 0000 0000000000
You’re viewing 5 of 32 competitors. Get the full list »

Igenomix Patents

Igenomix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220220564-A1 Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas Pending 17-Apr-2019 0000000000
EP-3956476-A1 Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas Pending 17-Apr-2019 0000000000
JP-2022529294-A Improved methods for early diagnosis of uterine leiomyoma and leiomyoma Pending 17-Apr-2019 0000000000
US-20210269862-A1 Methods for assessing endometrial transformation Pending 18-Jun-2018 0000000000 0
EP-3807648-A2 Methods for assessing endometrial transformation Inactive 18-Jun-2018 C12Q1/6816
To view Igenomix’s complete patent history, request access »

Igenomix Executive Team (7)

Name Title Board Seat Contact Info
David Jiménez Chief Executive Officer
Roseli Vendramini Controller
Carlos Simón Ph.D Co-Founder, Chief Scientific Officer & Head of Scientific Advisory Board
You’re viewing 3 of 7 executive team members. Get the full list »

Igenomix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Igenomix Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Igenomix‘s full profile, request access.

Request a free trial

Igenomix Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novalbufera Business 04-Jun-2021 00000 0000 Other Commercial Products
Access Genomics 14-Dec-2020 Buyout/LBO Laboratory Services (Healthcare) 00000 000
To view Igenomix’s complete investments history, request access »

Igenomix Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Access Genomics 14-Dec-2020 0000000000 Completed
  • 4 buyers
To view Igenomix’s complete exits history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »